Recurrence of SRF Post Intravitreal Ranibizumab for Pediatric Choroidal Neovascularisation Secondary to Best Disease

ABSTRACT

We present five cases of choroidal neovascularization secondary to pediatric Best disease which were treated with two different doses of intravitreal ranibizumab. Optical coherence tomography was used for monitoring of the cases. Three cases had subretinal fibrosis at presentation and two out of these 3 cases required repeat intravitreal ranibizumab at one year follow-up due to recurrence of subfoveal subretinal fluid.

Keywords:

• Best disease
• intravitreal ranibizumab
• vitelliform macular dystrophy

Acknowledgments

We would like to thank the Director General of Health Malaysia for his permission to publish this article.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.